Atlas Trials

Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients

Clinical trial NCT02010931 · COMPLETED

Trial details

NCT number
NCT02010931
Sponsor
Amgen
Status
COMPLETED
Study type
OBSERVATIONAL
Acute Lymphoblastic Leukemia
Start date
2013-09-01
Primary completion
2014-03-01
Enrollment
310

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.